MEGAN SCOTT: Open Payments
NPI 1780071605 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,661 in 152 payments from 37 companies in 2025. Trend: 2023 $3,712 · 2024 $4,050 · 2025 $3,661
Food & beverage: $3,062Long term medical supply or device loan: $583Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $774 |
| AstraZeneca Pharmaceuticals LP | 15 | $470 |
| Janssen Biotech, Inc. | 17 | $292 |
| Merck Sharp & Dohme LLC | 9 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $186 |
| PFIZER INC. | 13 | $176 |
| ABBVIE INC. | 6 | $124 |
| ARRAY BIOPHARMA INC | 6 | $111 |
| Daiichi Sankyo Inc. | 4 | $108 |
| Dendreon Pharmaceuticals LLC | 3 | $100 |
Products named: KISQALI, ENHERTU, Nubeqa, KEYTRUDA, TECVAYLI, PROVENGE, Lenvima, REBLOZYL.
Industry payments across FL — which companies pay providers there.
